Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trichloroacetic Acid SCHEMBL9721918 | 1.00 | TSHR (0.71) | TSHRALDH1A1TP53CAMK2ACYP1A2 | |
| Trichloroacetic Acid SCHEMBL9420645 | 0.87 | TSHR (0.62) | TSHRALDH1A1TP53CAMK2A | |
| Trichloroacetic Acid SCHEMBL38661501 | 0.84 | — | — | |
| Trichloroacetic Acid SCHEMBL5311061 | 0.84 | TSHR (1.00) | TSHRALDH1A1TP53CYP1A2CYP2D6 | |
| Trichloroacetic Acid SCHEMBL1331160 | 0.84 | — | — | |
| Trichloroacetic Acid SCHEMBL10493657 | 0.84 | TSHR (1.00) | TSHRALDH1A1TP53CYP1A2CYP2D6 | |
| Trichloroacetic Acid SCHEMBL3220 | 0.84 | — | — | |
| Trichloroacetic Acid SCHEMBL1331955 | 0.84 | — | — | |
| Trichloroacetic Acid SCHEMBL10745837 | 0.84 | — | — | |
| Trichloroacetic Acid SCHEMBL5874935 | 0.84 | TSHR (0.59) | TSHRALDH1A1TP53CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107969730-B | Preparation method of tobacco flavor microcapsule | 北京亚美方舟科贸有限公司 | 2020-04-14 | — | — | CN | claimed |
| CN-107969730-B | Preparation method of tobacco flavor microcapsule | 北京亚美方舟科贸有限公司 | 2020-04-14 | — | — | CN | disclosed |
| US-6001605-A | Gro genes | CHIRON CORPORATION (US) | 1999-12-14 | — | — | US | disclosed |
| US-5994060-A | Gro genes, proteins, and uses thereof | CHIRON CORPORATION (US) | 1999-11-30 | — | — | US | disclosed |
| US-5977323-A | Method of purifying Gro β or Gro α protein using antibodies | CHIRON CORPORATION (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0909817-A1 | Uses of gro genes and proteins | CHIRON CORPORATION (US) | 1999-04-21 | — | — | EP | disclosed |
| EP-0550661-B1 | USES OF GRO GENES AND PROTEINS | CHIRON CORP (US) | 1999-04-14 | — | — | EP | disclosed |
| EP-0534978-B1 | INTERLEUKIN-1 ANTAGONIST AND USES THEREOF | CHIRON CORP (US) | 1999-03-24 | — | — | EP | disclosed |
| US-5874561-A | AMINO ACID SEQUENCE OF INTERLEUKIN-1 ANTAGONIST; FOR DIAGNOSIS OF TUMORS AND IMMUNE DISEASES, ANTIARTHRITIC AGENTS, PRETREATMENT AND TREATMENT FOR SEPSIS | CHIRON CORPORATION/CHAPEL HILL NORTH CAROLINA (US) | 1999-02-23 | — | — | US | disclosed |
| US-5858688-A | Gro genes, proteins, and uses thereof | CHIRON CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
| US-5234839-A | Compositions for detecting ras gene proteins and cancer therapeutics | CETUS ONCOLOGY CORPORATION (US) | 1993-08-10 | — | — | US | disclosed |
| EP-0550661-A1 | GRO GENES, PROTEINS, AND USES THEREOF | CHIRON CORPORATION (US) | 1993-07-14 | — | — | EP | disclosed |
| EP-0534978-A1 | INTERLEUKIN-1 ANTAGONIST AND USES THEREOF | CHIRON CORPORATION (US) | 1993-04-07 | — | — | EP | disclosed |
| EP-0491828-A1 | PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF | CHIRON CORPORATION (US) | 1992-07-01 | — | — | EP | disclosed |
| WO-1992006196-A1 | GRO GENES, PROTEINS, AND USES THEREOF | CETUS ONCOLOGY CORPORATION (US) | 1992-04-16 | — | — | WO | disclosed |
| US-5104975-A | Pure, isolated protein which stimulates guanosine triphosphatase in non-oncogenic cells but not in oncogenic mutants | CETUS CORPORATION (US) | 1992-04-14 | — | — | US | disclosed |
| EP-0466688-A1 | GAP GENE SEQUENCES AND DIAGNOSTIC USES THEREOF. | CETUS CORP (US) | 1992-01-22 | — | — | EP | disclosed |
| WO-1991017249-A1 | INTERLEUKIN-1 ANTAGONIST AND USES THEREOF | CETUS CORPORATION (US) | 1991-11-14 | — | — | WO | disclosed |
| WO-1991002749-A1 | PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | CETUS CORPORATION (US) | 1991-03-07 | — | — | WO | disclosed |
| WO-1990000607-A2 | GAP GENE SEQUENCES AND DIAGNOSTIC USES THEREOF | CETUS CORPORATION (US) | 1990-01-25 | — | — | WO | disclosed |